RxDoctor Payments DataLook up a doctor →

Gregory Brown

Psychiatry · Shreveport, LANPI 1821058181

Payments from drug & device makers

$494,713in general payments, 2019–2025

Across 987 payments — averaging $501.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$154K
  • Neurocrine Biosciences, Inc.$138K
  • Supernus Pharmaceuticals, Inc.$79K
  • AbbVie$74K
  • Ironshore Pharmaceuticals Inc.$29K
  • Idorsia Pharmaceuticals US Inc$11K
  • plus $9K from 15 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Otsuka America Pharmaceutical, Inc.199$153,723
Neurocrine Biosciences, Inc.167$138,026
Supernus Pharmaceuticals, Inc.139$78,795
AbbVie(2 entities)189$74,286
Ironshore Pharmaceuticals Inc.60$29,379
Idorsia Pharmaceuticals US Inc6$11,087
Corium, LLC16$4,029
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)46$1,275
Alkermes, Inc.50$1,050
Lundbeck LLC39$680
Takeda Pharmaceuticals U.S.A., Inc.11$631
Sunovion Pharmaceuticals Inc.32$522
Axsome Therapeutics, Inc.6$448
E.r. Squibb & Sons, L.L.C.6$206
Shire North American Group Inc10$181
Johnson & Johnson4$177
Otsuka Pharmaceutical Development & Commercialization, Inc.1$109
Teva Pharmaceuticals USA, Inc.2$48
Vertical Pharmaceuticals, LLC2$29
Avanir Pharmaceuticals, Inc.1$18
Neos Therapeutics, LP1$17

How this compares

$494,713 in reported general payments places this provider in the 95th percentile of 474 psychiatry providers in Louisiana.

See all psychiatry providers in Louisiana →

Other psychiatry in Shreveport

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →